Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5807_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
26 Мб
Скачать
Chapter
Congenital anomalies and assisted
34
reproductive technologies
Mona Aboulghar

Introduction

The population of children born after assisted reproductive technologies (ART) has increased dramatically around the world. An explicit example is Denmark, where 4% of infants are born after in-vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) techniques, and 40% of these are twins [1]. There is naturally interest now in studying those children born regarding obstetric complications, congenital mal­formations, and long-term eects.

Risks associated with pregnancies following ART techniques

IVF pregnancies are associated with increased perinatal risks, of which multiple pregnancies are the most serious due to higher levels of obstetric complications [2,3,4].
Multiple pregnancies
Probably the highest risk result of IVF pregnancies is multiple pregnancy, which has been reported 27 times more frequently than in the general population [5].
The risks of multiple pregnancies include: perinatal morta­lity, preterm birth, low birth weight, gestational hypertension, placental abruption, and placenta previa [1,2]. The incidence of monozygotic twins is higher in ART pregnancies [6], and these are known to carry higher risks than dizygotic twins. Even when pregnancy starts with higher-order multiple pregnancy, the ongoing twins are still associated with a mild increased risk of premature delivery and low birth weight when compared with nonreduced twin pregnancies [7].
Increased perinatal morbidity is known to be higher in singleton ART pregnancies as well, which could be attributed to the underlying reproductive pathology [4].

Congenital malformations following IVF

Rizk and co-workers evaluated the congenital malformations in 961 babies conceived by IVF from Bourn Hall Clinic and the Hallam Medical Center between 1978 and 1987 [8]. The overall
prevalence of congenital malformation was 3%, and 2.5% of the babies had at least one major malformation diagnosed during the rst week of life (Table 34.1). The dierence between the two proportions is due to multiple malformations in some babies: ve babies had more than one malformation diagnosed under one week and two babies had more than one malforma­tion diagnosed at any time. Although the malformation rates were higher in multiple births than with singleton births, the dierences were not statistically signicant (Table 34.1). Rizk et al. [8] compared the congenital malformations in IVF babies born and conceived in the United Kingdom with three sources of control data. Congenital malformations diagnosed during the rst week of life were compared with the expected values from (1) the Oce of Population Censuses and Surveys (OPCS), which is a voluntary scheme of reporting malforma­tions diagnosed in the rst week of life in England and Wales h (adjusted for maternal age and multiplicity); and (2) the Scottish Information Statistics Division, which routinely abstracts data on the prevalence of malformations in the live-born in Scotland diagnosed before one week of life (adjusted for maternal age) (Table 34.2). Congenital abnormalities diagnosed at any time (including terminations) were compared with the expected maternal age-adjusted values from the Liverpool Congenital Malformations Register, which contains data from many sources on malformations diagnosed at any age in the ve health districts of the Liverpool region (UK) (Table 34.3). The information was presented system by system (Tables 34.2, 34.3). No specic malformations were signicantly increased, but higher than expected numbers of central nervous system, chromosomal, urogenital, and limb malformations were observed (Table 34.3).
However, more recently published reports have suggested an increased risk of birth defects in both IVF and ICSI preg­nancies (Tables 34.4, 34.5)[9](Figures 34.1, 34.2, 34.3, 34.4,
34.5, 34.6, 34.7, 34.8, 34.9, 34.10). Buckett et al. reported on all
ART procedure s, as compared with naturally conceived chil­dren; IVF, IVM (in-vitro maturation), and ICSI were found to have slightly higher risks of congenital malformations. Odds ratios for any congenital abnormality were 1.42 (95% con­dence interval [CI] 0.52–3.91) for IVM, 1.21 (95% CI 0.63– 2.62) for IVF, and 1.69 (95% CI 0.88–
3.26) for ICSI [3]. Olson et
al.
Ultrasonography in Reproductive Medicine and Infertility, ed. Botros R. M. B. Rizk. Published by Cambridge University Press. © Cambridge University Press 2010.
Section 4: Early pregnancy after infertility treatment
Table 34.1. Major malformations diagnosed within the rst week of life
of IVF babies
Singleton Multiple Total
Total major malformations (%) 2.9 3.3 3.0
Babies with at least one
major malformation (%)
Reproduced with permission from Rizk B, et al. [8].
Table 34.2. Observed and expected malformations diagnosed under one
week of age in IVF babies
Central nervous system 3 2.2/2.2
Chromosomal 5 1.8/2.5
Urogenital system 13 3.2/12.4
Limb 16 6.8/53.0
Alimentary system 2 2.5/3.4
Respiratory system 1 0.1/1.0
Cardiovascular system 7 1.8/10.1
Eye and ear 4 1.0/2.4
Other musculoskeletal 7 1.8/6.5
Skin and integument 4 1.9/30.7
Other 2 _
Total major malformations 29 15.0/30.8
Total babies with at least one major
malformation
Reproduced with permission from Rizk B, et al. [8].
2.4 2.7 2.5
Observed Expected
24 12.4/25.8
Table 34.3. Observed and expected malformations diagnosed at any time
(including termination) in IVF babies
Observed Expected
Central nervous system 5 2.8
Chromosomal 5 3.7
Urogenital system 3 1.9
Limb 8 5.4
Alimentary system 2 2.5
Respiratory system 1 0.4
Cardiovascular system 5 8.4
Eye and ear 1 1.4
Other musculoskeletal 2 2.0
Other 2 _
Total major malformations 34 29.0
Total babies with at least one major
malformation
Reproduced with permission from Rizk B, et al. [8].
32 25.3
Reasons for concern after ICSI procedures
Concerns about ICSI are related to technical, biological, and genetic hazards. The link to increased incidence of chromoso­mal anomalies, congenital abnormalities, and perinatal hazards has been attributed to abnormal semen, to abnormal karyotyp­ing, and to the technique of ICSI in which the oocyte membrane is pierced, bypassing the natural genetic selection that occurs in IVF [15].
reported a 1.3-fold higher risk in IVF and one of 1.1 for IUI (intrauterine insemination) pregnancies for birth defects when compared with naturally conceived babies [10].
An Australian study found the odds ratio (OR) for multiple major defects to be 2.0 in IVF and ICSI, which was higher than that in the general population of naturally conceived infants [11]. This agrees with an Israeli study [12], in which the increase in congenital malformations was 2.3 and 1.75 times higher than in the spontaneously conceived group.
A Danish study included a large number of IVF/ICSI births (8602) between 1995 and 2000, of which 3438 were twins (40%) and 5164 were singletons (60%). The incidence of malformations was similar in ICSI compared with IVF babies; however, the total malformation rate was signicantly higher in twins compared with singletons. A signicant increase in hypospadias was observed in ICSI babies [1]. This has been reported in several other studies, when testic­ular sperm were used [13].
A study on cryopreserved ICSI embryos found a 2-fold increased incidence of congenital malformations [14].

Comparison of risks following IVF and ICSI

Because of the dierence in technique used between ICSI and IVF where non-natural selection of the fertilizing sperm, and possible damage to the oocyte, occurs, there has been concern that ICSI could increase the risk of birth defects.
A follow-up study of 2059 neonates resulting from ICSI treatment [16], found 38 (1.8%) cases presenting with congen­ital abnormalities (22 major and 16 minor). Comparing the outcome of miscarriages and congenital malformations in terms of semen origin, ICSI and IVF were found not to dier.
A large prospective multicenter study including 59 centers in Germany compared the major malformation rate in ICSI pregnancies with that of naturally conceived controls [17]. A slight increase in malformations was reported, 8.6% versus
6.9%, resulting in a crude relative risk of 1.25 (95% CI
1.11–1.40). In their study they found no inuence of sperm origin on major malformation rate in children born after ICSI.
Bonduelle et al. [18,19], in two large published studies, reported on major malformations (dened as those causing func­tional impairment or requiring surgical correction). The risk was similar in both ICSI and live-bornIVF children:3.4% versus 3.8% (P = 0.538). The malformation rate in ICSI was not found to be related to sperm origin or sperm quality. The number of
284
Table 34.4. A summary of recent studies of IVF children and the risk of congenital anomalies
Chapter 34: Congenital anomalies
Number of
Author (year)
Zhu (2006) 1483 Population-based study Denmark 6.6% (hazard ratio 1.20)
Bonduelle (2005) 540 Population-based study Belgium OR 1.80
Kallen (2005) 16 280 Population-based registry Sweden 5% vs 4% (relative risk 1.26)
Klemetti (2005) 4559 Population-based registry Finland OR 1.3
Merlob (2005) 278 Population-based registry Israel 9.35% vs 4.05%
Olson (2005) 1462 Population-based registry USA 6.2% vs 4.4%
Anthony (2002) 4224 Population-based registry The Netherlands OR 1.20
Hansen (2002) 837 Population-based registry Australia 9% vs 4.2% (OR 2.0)
Isaksson (2002) 92 Case–control study Finland 7.2% vs 3.5% in singletons.
Koivurova (2002) 304 Population-based registry Finland 6.6% vs 4.4% (OR 1.53)
Ericson (2001) 9111 (estimated) Population-based study Sweden OR 0.89
Koudstaal (2000) 307 Clinic The Netherlands 2.3% (OR 1.0)
Bergh (1999) 5856 Population-based study Sweden 5.4% vs 3.9%
Bowen (1998) 84 Case–control study Australia 3.6% vs 5% (no signicant dierence)
Dsouza (1997) 278 Case–control study USA 2.5% vs 0%
Sutclie (1995) 91 Clinic UK OR 1.4
Reproduced with permission from Anpananthar A, SutclieA.[9].
Table 34.5. A summary of recent studies of ICSI children and the risk of congenital anomalies
IVF children Type Country
Risk of congenital anomaly in IVF vs. naturally conceived children ± odds ratio (OR)
Number of ICSI
Author (year)
Zhu (2006) 398 Population-based study Denmark 8.8% (hazard ratio 1.39)
Bonduelle (2005) 540 Population-based study Belgium 4.6% (OR 2.7)
Katalinic (2004) 3372 Tertiary infertility center Germany 8.7% vs 6.1% (OR 1.24%)
Hansen (2002) 301 Population-based study Australia 8.6% vs 4.2% (OR 2)
Ludwig (2002) 3372 Population-based study Germany 8.6% vs 6.9% (RR 1.25)
Sutclie (2001) 208 Case-control-study UK 4.8% vs 4.5% (OR 1.06)
Wennerholm (2000) 1139 Population-based study Sweden 7.6% (OR 1.75)
Bowen (1998) 89 Case-control study Australia 4.5% vs 5% (no signicant dierence)
Bonduelle (1996) 877 Population-based study Belgium 2.6% (within normal range)
Sutclie (1995) 56 Fertility center Australia OR 0.67
Reproduced with permission from Anpananthar A, SutclieA.[9].
stillbirths was similar in both groups (1.69% in the ICSI group versus 1.31% in the IVF). The total malformation rate taking into account major malformations in stillbirths, in termina­tions, and in live-born children was again similar (4.2% versus
children Type Country
excluding preterm deliveries. ICSI pregnancies were comparable to those from IVF, and both had worse perinatal outcomes than naturally conceived pregnancies. No long-term eects were observed in children up to the age of 5–8years.
Risk of congenital anomaly in ICSI vs. naturally conceived children ± odds ratio (OR)
4.6%, P = 0.482). A meta-analysis of 19 studies reported an OR of 1.29 for
congenital malformations, being similar in children born from IVF and ICSI [20].
Knoester et al. [21] compared singleton ICSI, IVF, and nat-
urally conceived children as regards congenital malformations and fetal growth, general health, and medical consumption,

Chromosomal abnormalities

Chromosomal study of abortuses following ART techniques showed no increase in the incidence of anomalies when com­pared with naturally conceived pregnancies, or between IVF (54.5%) and ICSI (61.5%), but there was an increase in ICSI
285
Section 4: Early pregnancy after infertility treatment
Figure 34.1. 2D image of acrania.
Figure 34.3. 3D image of median facial cleft.
Figure 34.2. 3D image of acrania.
TESE (testicular sperm extraction), and in cryo-oocytes and IUI pregnancies [22]. However, in another study [23], ICSI preg­nancies had a signicantly higher rate of chromosomal aberra­tions than IVF.
First-trimester screening using nuchal translucency
(NT) thickness, biochemical marker assessment, pregnancy­associated plasma protein A (PAPP-A), and free beta human chorionic gonadotropin (β-hCG) is now routine practice in many countries. Since the numbers of pregnancies following ART procedures are increasing around the world, it became necessary to determine whether any dierence could be detected in the rst-trimester screening among the naturally conceived population compared with the assisted-conception
population. A Danish study [24] compared 1000 pregnancies achieved after ART with a control group of 2543 pregnancies conceived spontaneously, as regards NT thickness, PAPP-A, and free β-hC G. In chromosomally normal pregnancies con­ceived after IVF and ICSI, the P APP-A MOMs (multiples of the median) values were signicantly decreased when com­pared with those of pregnancies conceived spontaneously (0.78 and 0.79 vs. 0.98), while there was no dierence in the group treated by frozen embryo replacement. There was no dierence in the level of free β-hCG between groups. The median nuchal translucency thickness was smaller in the over­all ART group than in controls. The false-positive rate of rst­trimester combined screening in the overall ART group, adjusted for maternal age, was signicantly higher than in controls (9.0% vs. 6.0%). This stresses the importance of including data of mode of conception while calculating the risk for Down syndrome in patients following ART procedures.

Reported anomalies following ART procedures

Specic anomalies reported with IVF include the extrophy epi­spadius complex, which showed a 7.3-fold relative increase in incidence in IVF infants (P = 0.0021) [25]. Reported anomalies having higher prevalence in ART techniques include gastrointest­inal (GI) (OR 9.85; 95% CI 3.44–28.44), cardiovascular (OR 2.30; 95% CI 1.11–4.77), and skeletal (OR 1.54; 95% CI 0.48–4.94) [9].
A review of our own data based on mid-trimester ultrasound examination of 1690 ICSI pregnancies showed 1018 singletons, 621 twins, 10 triplets, and 41 cases of anomalies representing
2.4%, of which 90.2% (37) were major and 9.7% minor [4]. This was compared with a control group of 3396 spontaneously pregnant patients: 3200 singletons, 99 twins, and 11 triplets, and 86 cases of anomalies (2.5%). Of those, 87.2% (75) were
286
Chapter 34: Congenital anomalies
a
Figure 34.4. (a) Septated cystic hygroma, 2D image. (b) Cystic hygroma.
b
Figure 34.5. Encephalocele.
major and 12.7% minor [11]. The odds ratio for incidence of anomalies in ICSI pregnancies was 1.04 (CI 0.71–1.52). These results were similar in twin ICSI and spontaneous groups: 2.5% and 3.5%, respectively (P = 0.50). (MMA Aboulghar, unpub­lished data). The most common anomalies were CNS –31% of the ICSI group compared with 37% in the spontaneous group; similarly, 31% renal anomalies compared with 18.6%, GI anomalies 31.7% and 12.7%, followed by skeletal 12.9% and
12.7%, heart anomalies 7.3% and 5.8%; no dierence was found in the type of anomalies. The incidence of anomalies agrees with several Egyptian studies. The incidence of congenital malforma­tions in live-born infants ranged from 1.16% to 3.17% [26].
Examples of detected anomalies are shown in Figures 34.1,
34.2, 34.3, 34.4, 34.5, 34.6, 34.7, 34.8, 34.9, and 34.10.

Intrauterine insemination (IUI) pregnancies

The rate of congenital malformations is not increased and no eect of frozen semen or donated semen has been conrmed
Figure 34.6. Kyphosoliosis.
from the literature. Reported incidence of malformations is
1.4% in singletons and 1.7% in twins; there was a slightly higher incidence of trisomy 21, possibly related to higher maternal age. The commonest malformations were cardiovascular, similar to the general population [27].
In the French registry, a higher rate of congenital malforma-
tions was found among IVF pregnancies compared with IUI,
2.7% compared with 1.9% (P = 0.009). However, this rate did not dier using husband semen or donor semen. The rate of trisomy 21 increased with maternal age as well as donor age [28]. Other reports agreed with these results and, in addition, assessment of the psychosocial development of such infants up to the age of 8–10 years appeared to be reassuring [29].

Anomalies after testicular sperm extraction (TESE)

The incidence of hypospadias was signicantly higher in the male ospring using epididymal or testicular sperm [13]. These ndings are supported by another study including IVF preg­nancies and was attributed to the high incidence of maternal progesterone administration [30]. Other malformations were
287
Section 4: Early pregnancy after infertility treatment
Figure 34.9. Holoprosencephaly.
Figure 34.7. Skeletal dysplasia, marked micromelia.
a
b
Figure 34.10. Facial cleft.
not found to be increased in ICSI children conceived with epididymal or testicular sperm when compared with malfor­mation rates for IVF or spontaneously conceived children [13]. The data published did not show any dierences between non­obstructive azoospermia (NOA) and obstructive azoospermia pregnancies, except for a strong tendency toward a lower gesta­tional age in singletons and a higher percentage of premature twins in the NOA group [31].
288

Congenital malformations in infertile patients conceiving naturally

Compared with singletons born of fertile couples, singletons born of infertile couples who had conceived naturally or after treatment had a higher prevalence of congenital malformation: hazard ratios – 1.20 (95% CI 1.07–1.35) and 1.39 (1.23–1.57). The overall prevalence of congenital malformations increased with increasing time to pregnancy [32]. It is suggested that the hormonal treatment used for infertility management may explain the occurrence of genital org an malformations.
Figure 34.8a, b. Ventriculomegaly.
Chapter 34: Congenital anomalies
However, the increased prevalence of congenital malforma­tions seen in singletons born after ART is partly due to under­lying infertility or its determinants [32].

Conclusion

ThepopulationofchildrenbornafterARThasincreased dramatically worldwide, and a literature search has shown increased perinatal risks with IVF pregnancies. Multiple pregnancies are the most serious due to higher obstetric complications. These include perinatal mortality, preterm birth, low birth weight, gestational hypertension, placental abruption, and placenta previa. The risks are higher with singleton pregnancies as well. Congenital malformations are reported to be higher in IVF and ICSI pregnancies, reach­ing an OR of 2.0 in some studies. These were signicantly higher in twins. Concern exists with the ICSI procedure, as it produces a non-natural selection of sperm and piercing of oocyte cytoplasm; however, studies comparing congenital malformations in ICSI with those in IVF showed no dier­ence in incidence.
First-trimester screening for chromosomal anomalies using PAPP-A and β-hCG, as well as NT thickness measurement, showed dierences between spontaneous and IVF pregnancies as well as a higher false-positive rate.
Some congenitalmalformations are more common following ART pregnancies, including hypospadias, especially after testic­ular sperm extraction, and the extrophy–epispadius complex.
In our own data of ultrasound-detected anomalies, the incidence of congenital malformations was similar between ICSI and spontaneous pregnancies.
Anomalies are not increased in IUI pregnancies.
The incidence of congenital malformations is higher in spontaneous pregnancies of infertile couples.

References

1. Pinborg A, Loft A, Nyboe
Andersen A, Neonatal outcome in a Danish national cohort of 8602 children born after in vitro fertilization or intracytoplasmic sperm injection: the role of twin pregnancy. Acta Obstet Gynecol Scand. 2004; 83(11): 1071–8.
2. Allen VM, Wilson RD,
Cheung A. Pregnancy outcomes after assisted reproductive technology. J Obstet Gynaecol Can. 2006 28(3): 220–50.
3. Buckett WM, Chian RC,
Holzer H, Dean N, Usher R, Tan SL. Obstetric outcomes and congenital abnormalities after in vitro maturation, in
vitro fertilization, and intracytoplasmic sperm injection. Obstet Gynecol 2007; 110(4): 885–91.
4. Reddy UM, Wapner RJ, Rebar RW, Tasca RJ. Infertility, assisted reproductive technology, and adverse pregnancy outcomes: executive summary of a National Institute of Child Health and Human Development workshop. Obstet Gynecol 2007; 109(4): 967–77.
5. Bergh T, Ericson A, Hillensjö T, Nygren KG, Wennerholm UB. Deliveries and children born after in-vitro fertilization in Sweden 1982–95: a retrospective cohort study. Lancet 1999; 354(9190): 1579–85.
6. Vitthala S, Gelbaya TA, Brison DR, Fitzgerald CT, Nardo LG. The risk of monozygotic twins after assisted reproductive technology: a systematic review and meta-analysis, Hum Reprod Update 2009; 15(1): 45–55.
7. Cheang CU, Huang LS, Lee TH, Liu CH, Shih YT, Lee MS. A comparison of the outcomes between twin and reduced twin pregnancies produced through assisted reproduction, Fertil Steril 2007; 88(1): 47–52.
8. Rizk B, Doyle P, Tan SL, et al. Perinatal outcome and congenital malformations in in-vitro fertilization babies from Bourn-Hallam group. Human Reprod 1991; 6(9): 1259–64.
9. Anpananthar A, SutclieA. Congenital anomalies and assisted reproductive technology. In: Rizk B, Garcia-Velasco JA, Sallam HN, Makrigiannakis A, eds.
Infertility and Assisted Reproduction, chapter 68.
Cambridge: Cambridge University Press, 2008; 684–94.
10. Olson CK, KM, Romitti PA, et al. In vitro fertilization is associated with an increase in major birth defects. Fertil Steril 2005; 84(5): 1308–15.
11. Hansen M, Kurinczuk JJ, Bower C, Webb S. The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. N Engl J Med 2002; 346(10): 725–30.
12. Merlob P, Sapir O, Sulkes J, Fisch B. The prevalence of major congenital malformations during two periods of time, 1986–1994 and 1995–2002 in newborns conceived by assisted reproduction technology. Eur J Med Genet 2005; 48(1): 5–11.
Keppler-Noreuil
13. Fedder J, Gabrielsen A, Humaidan P, Erb K, Ernst E, Loft A. Malformation rate and sex ratio in 412 children conceived with epididymal or testicular sperm. Hum Reprod 2007; 22(4): 1080–5.
14. Belva F, Henriet S, Van den Abbeel E, et al. Neonatal outcome of 937 children born after transfer of cryopreserved embryos obtained by ICSI and IVF and comparison with outcome data of fresh ICSI and IVF cycles. Hum Reprod 2008; 23(10): 2227–38.
15. Verpoest W, Tournaye H. ICSI: hype or hazard? Hum Fertil (Camb) 2006; 9(2): 81–92.
16. Palermo GD, Neri QV, Hariprashad JJ, Davis OK, Veeck LL, Rosenwaks Z. ICSI and its outcome. Semin Reprod Med 2000; 18(2): 161–9.
17. Ludwig M, Katalinic A. Malformation rate in fetuses and children conceived after ICSI: results of a prospective cohort study. Reprod Biomed Online 2002; 5(2): 171–8.
18. Bonduelle M, Liebaers I, Deketelaere V, et al. Neonatal data on a cohort of 2889 infants born after ICSI (1991–1999) and of 2995 infants born after IVF (1983–1999). Hum Reprod 2002; 17(3): 671–94.
Bonduelle M, Bergh C,
19. Niklasson A, Palermo GD, Wennerholm UB. York Medical follow-up of study of 5-year-old ICSI children. Reprod Biomed Online 2004; 9(1): 91–101.
20. Rimm AA, Katayama AC, Diaz M, Katayama KP. A meta-analysis of controlled studies comparing major malformation rates in IVF and ICSI infants with naturally conceived children. J Assist Reprod Genet 2004; 21(12): 437–43.
289
Section 4: Early pregnancy after infertility treatment
21. Knoester M, Helmerhorst FM, Vandenbroucke JP, van der Westerlaken LA, Walther FJ, Veen S. Leiden Articial Reproductive Techniques Follow-up Project (L-art­FUP), Perinatal outcome, health, growth, and medical care utilization of 5- to 8-year-old intracytoplasmic sperm injection singletons. Fertil Steril 2008; 89(5): 1133–46.
22. Bettio D, Venci A, Levi Setti PE. Chromosomal abnormalities in miscarriages after dierent assisted reproduction procedures. Placenta 2008; 29(Suppl B): 126–8.
23. Gjerris AC, Loft A, Pinborg A, Christiansen M, Tabor A. Prenatal testing among women pregnant after assisted reproductive techniques in Denmark
1995–2000: a national cohort study. Hum Reprod 2008; 23(7): 1545–52.
24. Gjerris AC, Loft A, Pinborg A, Christiansen M, Tabor A. First-trimester screening markers are altered in pregnancies conceived after IVF/ICSI. Ultrasound Obstet Gynecol 2009; 33(1): 8–17.
25. Wood HM, Trock BJ, Gearhart JP. In vitro fertilization and the cloacal­bladder exstrophy­epispadias complex: is there an association? J Urol 2003; 169(4): 1512–15.
26. Temtamy SA, Abdel Meguid N, Mazen I, Ismail SR, Kassem NS, Bassiouni RI. A genetic epidemiological study of malformations at birth in Egypt. Eastern Medit Health J 1998; 4: 252–9.
27. Thepot F, Mayaux MJ, Czyglick F, Wack T, Selva J, Jalbert P., Incidence of birth defects after articial insemination with frozen donor spermatozoa: a collaborative study of the French CECOS Federation on 11,535 pregnancies. Hum Reprod 1996; 11(10): 2319–23.
28. Lansac J, Thepot F, Mayaux MJ, et al. Pregnancy outcome after articial insemination or IVF with frozen semen donor: a collaborative study of the French CECOS Federation on 21,597 pregnancies. Eur
Reprod Biol 1997;
Gynecol
74(2): 223–8.
29. Lansac J, Royere D. Follow­up studies of children born after frozen sperm donation, Hum Reprod Update 2001; 7(1): 33–7.
J Obstet
30. Silver RI, Rodriguez R, Chang TS, Gearhart JP. In vitro fertilization is associated with an increased risk of hypospadias. J Urol 1999; 161(6): 1954–7.
31. Vernaeve V, Bonduelle M, Tournaye H, Camus M, Van Steirteghem A, Devroey P. Pregnancy outcome and neonatal data of children born after ICSI using testicular sperm in obstructive and non­obstructive azoospermia. Hum Reprod 2003; 18(10): 2093–7.
32. Zhu JL, Basso O, Obel C, Bille C, Olsen J. Infertility, infertility treatment, and congenital malformations: Danish national birth cohort. BMJ 2006; 333(7570): 679.
290
Chapter
Multiple pregnancy following IVF
35
James Hole, Kathy B. Porter, Sherri K. Taylor, Vicki Arguello, Robin Brown, Tiany Driver and Willie Cotten

Introduction

The diagnosis of multiple gestation is frequently met with joy and excitement by families who have undergone assisted repro­duction; however, the happiness is tempered when the realiza­tion occurs that this diagnosis places the mother and the gestation at signicantly increased risk for morbidity and mor­tality. The incidence of twin pregnancies in the United States has been increasing at an alarming rate from both delay of childbearing until later in life and, more importantly, the use of assisted reproductive techniques. The classically reported rate for spontaneous twinning is 1:80 and for triplets 1:6000 to 1:8000 [1,2 ]. When compared with natural ovulation, assis­ted reproduction signi cantly increases the chance of multiple gestation: 20-fold for twin gestation and 40-fold for triplets or quadruplets [3].
Twinning can be classied as either monozygotic (when a single fertilized ovum divides into two embry os) or dizygotic (when two separate ova are fertilized and implant in the same cycle). Monozygosity occurs in 31% of spontaneous twins, whereas dizygosity accounts for 69%. Most monozygotic twins are dichorionic/diamniotic (when division occurs within 3 days post fertilization) or monochorionic/diamniotic (divi­sion on days 4–8); however, when division occurs on days 8–12, the result will be a monochorionic/monoamniotic twin (approximately 1:10 000 pregnancies). If division is delayed until 13 days, the result is a conjoined twin. The incidence of monozygotic twinning has consistently reported to be stable at 4–5 per 1000 births. The incidence of dizygotic twinning con­tinues to vary depending on race and ethnicity, ranging from
1.3 per 1000 in Japan to 49 per 1000 in certain Nigerian tribes. The increase in twins has typically been from dizygotic gesta­tions, with no consistent increase in the rate of monozygosity. Higher-order multiple gestations (triplets or above) are usually combinations of multiple (di-, tri-, and higher) zygosity and monozygotic divisions within these (Figures 35.1, 35.2, 35.3,
35.4, 35.5).

Diagnosis

The diagnosis of spontaneous multiple gestation is often made when the clinical examina tion suggests size greater
than dates or during routine rst- or second-trimester dating or anatomical ultrasound evaluation. Multiple gestation in assisted reproduction is generally diagnosed very early dur­ing the post-therapy ultrasound evaluation. Ultrasound can usually delineate chorionicity, which should always be ascer­tained as early as possible in gestation. Monochorionicity has been shown to be a more important predictor of adverse outcome than zygosity [4]. The twin peak(also called lambda) sign is a very reliable marker for dichorionicity. The lack of this nding and the presence of the so-called Tsign strongly suggest monochorionicity ( Figures 35.6,
35.7). Other useful sonographic tools include the number
of yolk sacs, placental locations and apparent number, and fetal sex.

Complications

There is signicant increase in both maternal and fetal morbid­ity and mortality with multifetal pregnancies. Congenital anomalies, preterm birth, low birth weight, cerebral palsy, intracranial hemorrhage, blindness, and chronic pulmonary disease are among the more common known complications of twin gestations that occur either directly from the twinning or from prematurity [5]. From 1978 to 1987 at the Bourn Hall clinic and the Hallam Medical Center, Rizk et al. reported a 23% multiple pregnancy rate in 961 babies conceived by in-vitro fertilization [6]. Twins were present in 19% and triplets in 4% with no quadruplet or high-order multiple pregnancy. Overall, 32% were categorized as low birth weight and 6% as very low birth weight (Tables 35.1, 35.2). The perinatal mortal­ity rate was 2- to 3-fold higher than that of infants born in England and Wales; this is attributed to multiple pregnancy (Tables 35.3 , 35.4, 35.5). The congenital malformations were within expected range (2.5%), as discussed in Chapter 34.Tan et al. reported the obstetric outcome from the same series and highlighted the increased incidence of preeclampsia, placenta previa, and cesarean section [7]. Increased maternal morbid­ities included hypertension, gestational diabetes, anemia, pre­eclampsia, antepartum and postpartum hemorrhage, abnormal placentation, polyhydramnios and cesarean section [8,9]. Less frequently considered, but of signicant consequence, is the
Ultrasonography in Reproductive Medicine and Infertility, ed. Botros R. M. B. Rizk. Published by Cambridge University Press. © Cambridge University Press 2010.
Section 4: Early pregnancy after infertility treatment
Figure 35.1. First-trimester dichorionic twins.
Figure 35.2. First-trimester monochorionic twins.
Figure 35.4. Monochorionic/monoamniotic cord knot.
NOSE/LIPS
NOSE/LIPS
Figure 35.5. Conjoined twins.
292
Figure 35.3. Quadruplet gestation.
parenting stress sustained by the mothers and families of multi­ple gestations. A study of scores evaluating severe parental stressin IVF pregnancies gave results of 22% for multiples as compared with 5% for singletons [10].
Figure 35.6. Dichorionic twins, lambdasign.

Aneuploidy screening

Assessment for aneuploidy is an important aspect in the evalua­tion of abnormalities in any pregnancy, singleton or multiple. As